30 Jul 2024Open access3cites
Repurposing Antiviral Drugs as Potential Anti‐EGFR Agents in NSCLC: A Structure‐Based Screening and Molecular Dynamics AnalysisPublisher siteChemistry & Biodiversity, Lung Cancer Treatments and Mutations
Active, last published 2026
2
H-index
12
Citations
Fikayo has not officially claimed their profile. If you are Fikayo, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
research summary for Fikayo N. Adegboyega will appear here once their profile is updated.
02 · Reach
Publication output and reach
Fikayo's work has been cited 12 times across 2 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
04 · Where I am
Affiliations
Affiliation on published researchEgypt-Japan University of Science and Technology, EgyptDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
4 works22 May 2024Open access
Disruption of Oncogenic MCL-1-BAX/BAK Interaction Using Integrase Inhibitors: Insights from a Molecular Docking and Dynamic ExplorationPublisher siteResearch Square, Ubiquitin and proteasome pathways
14 Jun 2023Open access7cites
Molecular docking appraisal of Dysphania ambrosioides phytochemicals as potential inhibitor of a key triple-negative breast cancer driver genePublisher siteIn Silico Pharmacology, Traditional and Medicinal Uses of Annonaceae
27 Apr 2023Open access2cites
Molecular Docking Appraisal of Dysphania ambrosioides Phytochemicals as Potential Inhibitor of a Key Triple-negative Breast Cancer Driver GenePublisher siteResearch Square, Computational Drug Discovery Methods
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Fikayo?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you